Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 20, 2011 - Issue 5
Submit an article Journal homepage
1,406
Views
66
CrossRef citations to date
0
Altmetric
Reviews

Lysophosphatidic acid-1-receptor targeting agents for fibrosis

Chloé Rancoule Inserm, U1048/I2MC, 1 avenue Jean Poulhès, BP 84225, 31432 Toulouse Cedex 4, France [email protected]; Université Toulouse III Paul Sabatier, Institut de Médecine Moléculaire de Rangueil, Toulouse, F-31000 France
,
Jean-Philippe Pradère Columbia University, College of Physicians and Surgeons, Department of Medicine, NY 10032, USA
,
Julien Gonzalez Inserm, U1048/I2MC, 1 avenue Jean Poulhès, BP 84225, 31432 Toulouse Cedex 4, France [email protected]; Université Toulouse III Paul Sabatier, Institut de Médecine Moléculaire de Rangueil, Toulouse, F-31000 France
,
Julie Klein Inserm, U1048/I2MC, 1 avenue Jean Poulhès, BP 84225, 31432 Toulouse Cedex 4, France [email protected]; Université Toulouse III Paul Sabatier, Institut de Médecine Moléculaire de Rangueil, Toulouse, F-31000 France
,
Philippe Valet Inserm, U1048/I2MC, 1 avenue Jean Poulhès, BP 84225, 31432 Toulouse Cedex 4, France [email protected]; Université Toulouse III Paul Sabatier, Institut de Médecine Moléculaire de Rangueil, Toulouse, F-31000 France
,
Jean-Loup Bascands Inserm, U1048/I2MC, 1 avenue Jean Poulhès, BP 84225, 31432 Toulouse Cedex 4, France [email protected]; Université Toulouse III Paul Sabatier, Institut de Médecine Moléculaire de Rangueil, Toulouse, F-31000 France
,
Joost P Schanstra Inserm, U1048/I2MC, 1 avenue Jean Poulhès, BP 84225, 31432 Toulouse Cedex 4, France [email protected]; Université Toulouse III Paul Sabatier, Institut de Médecine Moléculaire de Rangueil, Toulouse, F-31000 France
&
Jean-Sébastien Saulnier-Blache Inserm, U1048/I2MC, 1 avenue Jean Poulhès, BP 84225, 31432 Toulouse Cedex 4, France [email protected]; Université Toulouse III Paul Sabatier, Institut de Médecine Moléculaire de Rangueil, Toulouse, F-31000 France
 show all
Pages 657-667 | Published online: 24 Mar 2011

Citations (66)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zhihao Gu, Yong Yan, Hequan Yao, Kejiang Lin & Xuanyi Li. (2022) Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present). Expert Opinion on Therapeutic Patents 32:10, pages 1097-1122.
Read now
Cuicui Cong, Lijun Mao, Yanlin Zhang, Zanmei Zhao, Xixian Xu & Jinyuan Zhao. (2014) Regulation of silicosis formation by lysophosphatidic acid and its receptors. Experimental Lung Research 40:7, pages 317-326.
Read now

Articles from other publishers (64)

Reza Akbarzadeh, Antje Müller, Jens Y. Humrich & Gabriela Riemekasten. (2023) When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis. Frontiers in Immunology 14.
Crossref
Yuewu Wang, Zhimin Qi, Ze Li, Shuyu Bai & Alatangaole Damirin. (2022) LPAR2-mediated action promotes human renal cell carcinoma via MAPK/NF-κB signaling to regulate cytokine network. Journal of Cancer Research and Clinical Oncology 149:5, pages 2041-2055.
Crossref
Francesca M. Trovato, Rabiya Zia, Florent Artru, Salma Mujib, Ellen Jerome, Anna Cavazza, Muireann Coen, Ian Wilson, Elaine Holmes, Phillip Morgan, Arjuna Singanayagam, Christine Bernsmeier, Salvatore Napoli, William Bernal, Julia Wendon, Rosa Miquel, Krishna Menon, Vishal C. Patel, John Smith, Stephen R. Atkinson, Evangelos Triantafyllou & Mark J.W. McPhail. (2023) Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure. Journal of Hepatology 78:3, pages 558-573.
Crossref
Benjamin E. Decato, Diana Julie Leeming, Jannie Marie Bülow Sand, Aryeh Fischer, Shuyan Du, Scott M. Palmer, Morten Karsdal, Yi Luo & Anne Minnich. (2022) LPA1 antagonist BMS-986020 changes collagen dynamics and exerts antifibrotic effects in vitro and in patients with idiopathic pulmonary fibrosis. Respiratory Research 23:1.
Crossref
Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, Toby M Maher, Jonathan G Goldin, Scott M Palmer, Takafumi Suda, Takashi Ogura, Anne Minnich, Xiaojiang Zhan, Giridhar S Tirucherai, Brandon Elpers, Hong Xiao, Hideaki Watanabe, R Adam Smith, Edgar D Charles & Aryeh Fischer. (2021) Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA 1 ) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD) . BMJ Open Respiratory Research 8:1, pages e001026.
Crossref
Toshihiko Tsutsumi, Masaki Ino, Yoshibumi Shimizu, Kohei Kawabata, Hiroyuki Nishi & Akira Tokumura. (2021) Altered plasma levels of lysophospholipids in response to adrenalectomy of rats. Prostaglandins & Other Lipid Mediators 156, pages 106579.
Crossref
Bhagyalalitha Meduri, Gurubasavaraj Veeranna Pujar, T. Durai Ananda Kumar, H.S. Akshatha, Arun Kumar Sethu, Manisha Singh, Abhinav Kanagarla & Bijo Mathew. (2021) Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development. European Journal of Medicinal Chemistry 222, pages 113574.
Crossref
Hui Geng, Rongpei Lan, Yaguang Liu, Wei Chen, Meng Wu, Pothana Saikumar, Joel M. Weinberg & Manjeri A. Venkatachalam. (2021) Proximal tubule LPA1 and LPA2 receptors use divergent signaling pathways to additively increase profibrotic cytokine secretion. American Journal of Physiology-Renal Physiology 320:3, pages F359-F374.
Crossref
Tatiana Kisseleva & David Brenner. (2020) Molecular and cellular mechanisms of liver fibrosis and its regression. Nature Reviews Gastroenterology & Hepatology 18:3, pages 151-166.
Crossref
David N. Brindley & Afshin Raouf. 2021. Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance. Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance 47 63 .
Laetitia Ledein, Bertrand Léger, Clara Dees, Christian Beyer, Alfiya Distler, Serena Vettori, Rachid Boukaiba, Jean Pierre Bidouard, Matthias Schaefer, Josef Pernerstorfer, Hartmut Ruetten, Alexandre Jagerschmidt, Philip Janiak, Jörg H.W. Distler, Oliver Distler & Stéphane Illiano. (2020) Translational engagement of lysophosphatidic acid receptor 1 in skin fibrosis: from dermal fibroblasts of patients with scleroderma to tight skin 1 mouse. British Journal of Pharmacology 177:18, pages 4296-4309.
Crossref
David N. Brindley, Xiaoyun Tang, Guanmin Meng & Matthew G. K. Benesch. (2020) Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer. International Journal of Molecular Sciences 21:16, pages 5938.
Crossref
Chao Sun, Han Zhang, Xiang Wang & Xinhui Liu. (2020) Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions. The FASEB Journal 34:8, pages 9854-9868.
Crossref
Xiaoyun Tang, Matthew G.K. Benesch & David N. Brindley. (2020) Role of the autotaxin–lysophosphatidate axis in the development of resistance to cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1865:8, pages 158716.
Crossref
Guanmin Meng, Melinda Wuest, Xiaoyun Tang, Jennifer Dufour, Todd P.W. McMullen, Frank Wuest, David Murray & David N. Brindley. (2020) Dexamethasone Attenuates X-Ray-Induced Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle in Breast Tissue and Subsequent Breast Fibrosis. Cancers 12:4, pages 999.
Crossref
Matthew G. K. Benesch, Xiaoyun Tang & David N. Brindley. (2020) Autotaxin and Breast Cancer: Towards Overcoming Treatment Barriers and Sequelae. Cancers 12:2, pages 374.
Crossref
Xiaoyun Tang, Melinda Wuest, Matthew G.K. Benesch, Jennifer Dufour, YuanYuan Zhao, Jonathan M. Curtis, Alain Monjardet, Bertrand Heckmann, David Murray, Frank Wuest & David N. Brindley. (2020) Inhibition of Autotaxin with GLPG1690 Increases the Efficacy of Radiotherapy and Chemotherapy in a Mouse Model of Breast Cancer. Molecular Cancer Therapeutics 19:1, pages 63-74.
Crossref
Guanmin Meng, Melinda Wuest, Xiaoyun Tang, Jennifer Dufour, YuanYuan Zhao, Jonathan M. Curtis, Todd P. W. McMullen, David Murray, Frank Wuest & David N. Brindley. (2019) Repeated Fractions of X-Radiation to the Breast Fat Pads of Mice Augment Activation of the Autotaxin-Lysophosphatidate-Inflammatory Cycle. Cancers 11:11, pages 1816.
Crossref
Ioanna Ninou, Eleanna Kaffe, Stefan Müller, David C. Budd, Christopher S. Stevenson, Christoph Ullmer & Vassilis Aidinis. (2018) Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics 52, pages 32-40.
Crossref
Yannick Allanore, Oliver Distler, Alexandre Jagerschmidt, Stephane Illiano, Laetitia Ledein, Eric Boitier, Inoncent Agueusop, Christopher P. Denton & Dinesh Khanna. (2018) Lysophosphatidic Acid Receptor 1 Antagonist SAR100842 for Patients With Diffuse Cutaneous Systemic Sclerosis. Arthritis & Rheumatology 70:10, pages 1634-1643.
Crossref
Andrea Hermina Györfi, Alexandru-Emil Matei & Jörg H.W. Distler. (2018) Targeting TGF-β signaling for the treatment of fibrosis. Matrix Biology 68-69, pages 8-27.
Crossref
Danielle Brooks, Alexandra Zimmer, Lalage Wakefield, L. Tiffany Lyle, Simone Difilippantonio, Fabio C. Tucci, Stephane Illiano, Christina M. Annunziata & Patricia S. Steeg. (2018) Limited fibrosis accompanies triple-negative breast cancer metastasis in multiple model systems and is not a preventive target. Oncotarget 9:34, pages 23462-23481.
Crossref
Jean-Dominique Gallezot, Nabeel B. Nabulsi, Daniel Holden, Shu-Fei Lin, David Labaree, Jim Ropchan, Soheila Najafzadeh, David J. Donnelly, Kai Cao, Samuel Bonacorsi, Jon Seiders, Jeffrey Roppe, Wendy Hayes, Yiyun Huang, Shuyan Du & Richard E. Carson. (2018) Evaluation of the Lysophosphatidic Acid Receptor Type 1 Radioligand 11 C-BMT-136088 for Lung Imaging in Rhesus Monkeys . Journal of Nuclear Medicine 59:2, pages 327-333.
Crossref
Qingyu Xu, Junfei Gu, You Lv, Jiarui Yuan, Nan Yang, Juan Chen, Chunfei Wang, Xuefeng Hou, Xiaobin Jia, Liang Feng & Guowen Yin. (2018) Angiogenesis for tumor vascular normalization of Endostar on hepatoma 22 tumor-bearing mice is involved in the immune response. Oncology Letters.
Crossref
Ingrid Saba, Weronika Jakubowska, Stéphane Bolduc & Stéphane Chabaud. (2018) Engineering Tissues without the Use of a Synthetic Scaffold: A Twenty-Year History of the Self-Assembly Method. BioMed Research International 2018, pages 1-13.
Crossref
Phornpimon Tipthara & Visith Thongboonkerd. 2018. Lipidomics in Health & Disease. Lipidomics in Health & Disease 97 111 .
Gerhard Rogler. 2018. Fibrostenotic Inflammatory Bowel Disease. Fibrostenotic Inflammatory Bowel Disease 295 305 .
John Varga, Maria Trojanowska & Masataka Kuwana. (2017) Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. Journal of Scleroderma and Related Disorders 2:3, pages 137-152.
Crossref
Guanmin Meng, Xiaoyun Tang, Zelei Yang, Matthew G. K. Benesch, Alison Marshall, David Murray, Denise G. Hemmings, Frank Wuest, Todd P. W. McMullen & David N. Brindley. (2017) Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy. The FASEB Journal 31:9, pages 4064-4077.
Crossref
Jean-Sébastien Saulnier-Blache, Eva Feigerlova, Jean Michel Halimi, Pierre Gourdy, Ronan Roussel, Bruno Guerci, Aude Dupuy, Justine Bertrand-Michel, Jean-Loup Bascands, Samy Hadjadj & Joost P. Schanstra. (2017) Urinary lysophopholipids are increased in diabetic patients with nephropathy. Journal of Diabetes and its Complications 31:7, pages 1103-1108.
Crossref
Chloé Rancoule, Sophie Espenel, Jane-Chloé Trone, Julien Langrand-Escure, Alexis Vallard, Amel Rehailia-Blanchard, Anis El Meddeb Hamrouni, Yaxiong Xia, Jean-Baptiste Guy, Majed Ben-Mrad & Nicolas Magné. (2017) Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index. Oncotarget 8:26, pages 43543-43554.
Crossref
Kai Zhang, Wei Sun, Xin-yu Liu, Chang-qing Zhao, Hua Li, Xiao-jiang Sun, Xie You-zhuan, Wei Ding & Jie Zhao. (2017) Hypertrophy and Fibrosis of the Ligamentum Flavum in Lumbar Spinal Stenosis is Associated With Increased Expression of LPA and LPAR1. Clinical Spine Surgery: A Spine Publication 30:3, pages E189-E191.
Crossref
Xueyu Chen, Frans J. Walther, El H. Laghmani, Annemarie M. Hoogeboom, Anne C. B. Hogen-Esch, Ingrid van Ark, Gert Folkerts & Gerry T. M. Wagenaar. (2017) Adult Lysophosphatidic Acid Receptor 1-Deficient Rats with Hyperoxia-Induced Neonatal Chronic Lung Disease Are Protected against Lipopolysaccharide-Induced Acute Lung Injury. Frontiers in Physiology 8.
Crossref
Yi-Min Liu, Kunal Nepali & Jing-Ping Liou. (2016) Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets. Journal of Medicinal Chemistry 60:2, pages 527-553.
Crossref
Gang Wang, Hao Jiao, Jun-Nian Zheng & Xia Sun. (2017) HSP27 regulates TGF-β mediated lung fibroblast differentiation through the Smad3 and ERK pathways. International Journal of Molecular Medicine 39:1, pages 183-190.
Crossref
Maria Trojanowska & John Varga. 2017. Scleroderma. Scleroderma 261 280 .
Naoto Kajitani, Kanako Miyano, Mami Okada-Tsuchioka, Hiromi Abe, Kei Itagaki, Kazue Hisaoka-Nakashima, Norimitsu Morioka, Yasuhito Uezono & Minoru Takebayashi. (2016) Identification of Lysophosphatidic Acid Receptor 1 in Astroglial Cells as a Target for Glial Cell Line-derived Neurotrophic Factor Expression Induced by Antidepressants. Journal of Biological Chemistry 291:53, pages 27364-27370.
Crossref
Koryun Mirzoyan, Anna Ba?otto, Aude Dupuy, Dimitri Marsal, Colette Denis, Claire Vinel, Pierre Sicard, Justine Bertrand-Michel, Jean-Loup Bascands, Joost P. Schanstra, Julie Klein & Jean-S?bastien Saulnier-Blache. (2016) Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: potential involvement in chronic kidney disease. Journal of Physiology and Biochemistry 72:4, pages 803-812.
Crossref
B. Hinz. (2016) The role of myofibroblasts in wound healing. Current Research in Translational Medicine 64:4, pages 171-177.
Crossref
X. Chen, F. J. Walther, R. van Boxtel, E. H. Laghmani, R. M. A. Sengers, G. Folkerts, M. C. DeRuiter, E. Cuppen & G. T. M. Wagenaar. (2016) Deficiency or inhibition of lysophosphatidic acid receptor 1 protects against hyperoxia-induced lung injury in neonatal rats. Acta Physiologica 216:3, pages 358-375.
Crossref
Christian Carpéné, Jean Galitzky & Jean Sébastien Saulnier-Blache. (2016) Short-term and rapid effects of lysophosphatidic acid on human adipose cell lipolytic and glucose uptake activities. AIMS Molecular Science 3:2, pages 222-237.
Crossref
B. Hinz. 2016. Wound Healing Biomaterials. Wound Healing Biomaterials 69 100 .
Xiang Xue, Qing Chen, Gang Zhao, Jin-Yan Zhao, Zhao Duan & Peng-Sheng Zheng. (2015) The Overexpression of TGF-? and CCN2 in Intrauterine Adhesions Involves the NF-?B Signaling Pathway. PLOS ONE 10:12, pages e0146159.
Crossref
Paul R. Territo, Mary Maluccio, Amanda A. Riley, Brian P. McCarthy, James Fletcher, Mark Tann, Romil Saxena & Nicholas J. Skill. (2015) Evaluation of 11C-Acetate and 18 F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma. BMC Medical Imaging 15:1.
Crossref
Stéphane Chabaud, Thomas-Louis Marcoux, Marie-Pier Deschênes-Rompré, Alexandre Rousseau, Amélie Morissette, Sara Bouhout, Geneviève Bernard & Stéphane Bolduc. (2015) Lysophosphatidic acid enhances collagen deposition and matrix thickening in engineered tissue. Journal of Tissue Engineering and Regenerative Medicine 9:11, pages E65-E75.
Crossref
Christina C. Leslie. (2015) Cytosolic phospholipase A2: physiological function and role in disease. Journal of Lipid Research 56:8, pages 1386-1402.
Crossref
CHUANYUE ZONG, XIANLONG ZHANG, YING XIE & JIAWEN CHENG. (2015) Transforming growth factor-β inhibits IQ motif containing guanosine triphosphatase activating protein 1 expression in lung fibroblasts via the nuclear factor-κB signaling pathway. Molecular Medicine Reports 12:1, pages 442-448.
Crossref
Xia Sun, Erjun Chen, Rui Dong, Weiguo Chen & Ying Hu. (2015) Nuclear factor (NF)-?B p65 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-?. Life Sciences 122, pages 8-14.
Crossref
Alexandra S. Zimmer & Patricia S. Steeg. (2014) Meaningful prevention of breast cancer metastasis: candidate therapeutics, preclinical validation, and clinical trial concerns. Journal of Molecular Medicine 93:1, pages 13-29.
Crossref
Achyutharao Sidduri, David C. Budd, Maria E. Fuentes, Ted Lambros, Yonglin Ren, Vikram Roongta, Ryan C. Schoenfeld, Paul Gillespie, Christopher S. Stevenson, Theresa Truitt & Yimin Qian. (2014) Discovery of novel non-carboxylic acid 5-amino-4-cyanopyrazole derivatives as potent and highly selective LPA1R antagonists. Bioorganic & Medicinal Chemistry Letters 24:18, pages 4450-4454.
Crossref
Jian Li, Gang Wang & Xia Sun. (2014) Transforming growth factor β regulates β-catenin expression in lung fibroblast through NF-κB dependent pathway. International Journal of Molecular Medicine.
Crossref
Kerri J. Grove, Paul A. Voziyan, Jeffrey M. Spraggins, Suwan Wang, Paisit Paueksakon, Raymond C. Harris, Billy G. Hudson & Richard M. Caprioli. (2014) Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles. Journal of Lipid Research 55:7, pages 1375-1385.
Crossref
Gerhard Rogler. (2014) New Therapeutic Avenues for Treatment of Fibrosis: Can We Learn from Other Diseases?. Digestive Diseases 32:Suppl. 1, pages 39-49.
Crossref
Ying Xie, Ye Wang, Chuanyue Zong & Jiawen Cheng. (2014) Transforming Growth Factor-Beta Inhibits Heme Oxygenase-1 Expression in Lung Fibroblasts through Nuclear Factor-Kappa-B-Dependent Pathway. Pharmacology 93:3-4, pages 185-192.
Crossref
C. Y. Nie, T. Han, L. Zhang, Y. Li, H. Liu, S. X. Xiao, Y. Li, H. Kang & S. Y. Liu. (2014) Cross-sectional and dynamic change of serum metabolite profiling for Hepatitis B-related acute-on-chronic liver failure by UPLC/MS. Journal of Viral Hepatitis 21:1, pages 53-63.
Crossref
Chloé Rancoule, Manon Viaud, Sandra Gres, Nathalie Viguerie, Pauline Decaunes, Anne Bouloumié, Dominique Langin, Jean-Loup Bascands, Philippe Valet & Jean Sébastien Saulnier-Blache. (2014) Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: In vivo and in vitro evidence. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1841:1, pages 88-96.
Crossref
David C Budd & Yimin Qian. (2013) Development of lysophosphatidic acid pathway modulators as therapies for fibrosis. Future Medicinal Chemistry 5:16, pages 1935-1952.
Crossref
C. Rancoule, C. Attan?S. Gr?s, A. Fournel, R. Dusaulcy, C. Bertrand, C. Vinel, K. Tr?guer, M. Prentki, P. Valet & J. S. Saulnier-Blache. (2013) Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice. Diabetologia 56:6, pages 1394-1402.
Crossref
Chloé Rancoule, Rodolphe Dusaulcy, Karine Tréguer, Sandra Grès, Charlotte Guigné, Didier Quilliot, Philippe Valet & Jean Sébastien Saulnier-Blache. (2012) Depot-specific regulation of autotaxin with obesity in human adipose tissue. Journal of Physiology and Biochemistry 68:4, pages 635-644.
Crossref
Yong Wei, Shao-wen Liu, Li-qun Zhao, Gen-qing Zhou, Song-wen Chen & Hongli Li. (2012) Lysophosphatidic acid as a potential trigger of atrial fibrillation. Medical Hypotheses 79:5, pages 649-652.
Crossref
Yimin Qian, Matthew Hamilton, Achyutharao Sidduri, Stephen Gabriel, Yonglin Ren, Ruoqi Peng, Rama Kondru, Arjun Narayanan, Terry Truitt, Rachid Hamid, Yun Chen, Lin Zhang, Adrian J. Fretland, Ruben Alvarez Sanchez, Kung-Ching Chang, Matthew Lucas, Ryan C. Schoenfeld, Dramane Laine, Maria E. Fuentes, Christopher S. Stevenson & David C. Budd. (2012) Discovery of Highly Selective and Orally Active Lysophosphatidic Acid Receptor-1 Antagonists with Potent Activity on Human Lung Fibroblasts. Journal of Medicinal Chemistry 55:17, pages 7920-7939.
Crossref
Zhizhong Guo, Shuhao Yu, Yan Guan, Ying-Ya Li, Yi-Yu Lu, Hui Zhang & Shi-Bing Su. (2012) Molecular Mechanisms of Same TCM Syndrome for Different Diseases and Different TCM Syndrome for Same Disease in Chronic Hepatitis B and Liver Cirrhosis. Evidence-Based Complementary and Alternative Medicine 2012, pages 1-9.
Crossref
Swati Bhattacharyya, Jun Wei & John Varga. (2011) Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nature Reviews Rheumatology 8:1, pages 42-54.
Crossref
John Varga. 2012. Scleroderma. Scleroderma 255 265 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.